L. Davies and H. G. Welch, Increasing incidence of thyroid cancer in the United States, JAMA, vol.295, p.16684987, 1973.

B. R. Haugen, E. K. Alexander, K. C. Bible, G. M. Doherty, S. J. Mandel et al., American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer, Thyroid, vol.26, p.26462967, 2015.

I. D. Hay, E. J. Bergstralh, J. R. Goellner, J. R. Ebersold, and C. S. Grant, Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989, Surgery, vol.114, p.8256208, 1993.

S. Leboulleux, C. Rubino, E. Baudin, B. Caillou, D. M. Hartl et al., Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis, J Clin Endocrinol Metab, vol.90, p.16030160, 2005.

A. Mendoza, B. Shaffer, D. Karakla, M. E. Mason, D. Elkins et al., Quality of life with well-differentiated thyroid cancer: treatment toxicities and their reduction, Thyroid, vol.14, p.15068628, 2004.

E. Ruel, S. Thomas, M. Dinan, J. M. Perkins, S. A. Roman et al., Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer, J Clin Endocrinol Metab, vol.100, p.25642591, 2015.

K. Y. Bilimoria, D. J. Bentrem, C. Y. Ko, A. K. Stewart, D. P. Winchester et al., Extent of surgery affects survival for papillary thyroid cancer, Ann Surg, vol.246, p.17717441, 2007.

C. Schvartz, F. Bonnetain, S. Dabakuyo, M. Gauthier, A. Cueff et al., Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients, J Clin Endocrinol Metab, vol.97, p.22344193, 2012.

J. Jonklaas, G. Nogueras-gonzalez, M. Munsell, D. Litofsky, K. B. Ain et al., The impact of age and gender on papillary thyroid cancer survival, J Clin Endocrinol Metab, vol.97, p.22496497, 2012.

T. Ibrahimpasic, R. Ghossein, D. L. Carlson, I. Nixon, F. L. Palmer et al., Outcomes in patients with poorly differentiated thyroid carcinoma, J Clin Endocrinol Metab, vol.99, p.24512493, 2014.

M. Haq and C. Harmer, Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome, Clin Endocrinol (Oxf), vol.63, p.15963067, 2005.

F. Kwiatkowski, M. Girard, K. Hacene, and J. Berlie,

, Bull Cancer, vol.87, p.11084535, 2000.

A. M. Sawka, K. Thephamongkhol, M. Brouwers, L. Thabane, G. Browman et al., Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer, J Clin Endocrinol Metab, vol.89, p.15292285, 2004.

M. A. Adam, J. Pura, L. Gu, M. A. Dinan, D. S. Tyler et al., Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients, Ann Surg, vol.260, p.25203876, 2014.

P. G. Calò, G. Conzo, M. Raffaelli, F. Medas, C. Gambardella et al., Total thyroidectomy alone versus ipsilateral versus bilateral prophylactic central neck dissection in clinically node-negative differentiated thyroid carcinoma. A retrospective multicenter study, Eur J Surg Oncol, vol.43, p.27780677, 2017.

G. Conzo, E. Tartaglia, N. Avenia, P. G. Calò, A. De-bellis et al., Role of prophylactic central compartment lymph node dissection in clinically N0 differentiated thyroid cancer patients: analysis of risk factors and review of modern trends, World J Surg Oncol, vol.14, p.27185169, 2016.

B. Barres, A. Kelly, F. Kwiatkowski, M. Batisse-lignier, G. Fouilhoux et al., Stimulated thyroglobulin and Thyroglobulin Reduction Index Predict Excellent Response in Differentiated Thyroid Cancers, J Clin Endocrinol Metab, p.30785995, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02089771

T. J. Matthews, E. Chua, A. Gargya, J. Clark, K. Gao et al., Elevated serum thyroglobulin levels at the time of ablative radioactive iodine therapy indicate a worse prognosis in thyroid cancer: an Australian retrospective cohort study, J Laryngol Otol, vol.130, issue.4, p.27488338, 2016.

Y. D. Podnos, D. Smith, L. D. Wagman, and J. Ellenhorn, The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer, Am Surg, vol.71, p.16468507, 2005.

V. Zaydfudim, I. D. Feurer, M. R. Griffin, and J. E. Phay, The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma, Surgery, vol.144, p.19041020, 2008.

A. R. Shaha, J. P. Shah, and T. R. Loree, Risk group stratification and prognostic factors in papillary carcinoma of thyroid, Ann Surg Oncol, vol.3, p.8915484, 1996.

R. M. Tuttle, B. Haugen, and N. D. Perrier, Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?, Thyroid, vol.27, p.28463585, 2017.

I. J. Nixon, L. Y. Wang, J. C. Migliacci, A. Eskander, M. J. Campbell et al., An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer, Thyroid, vol.26, p.26914539, 2016.